Literature DB >> 2982267

Controversies in Rh prophylaxis. Who needs Rh immune globulin and when should it be given?

J M Bowman.   

Abstract

A summary of the current recommendations for administration of Rh immune globulin after several reproductive events is presented. The risks of failure to administer Rh immune globulin after delivery or abortion, amniocentesis, and massive transplacental hemorrhage are described.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2982267     DOI： 10.1016/0002-9378(85)90288-1

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN： 0002-9378            Impact factor:   8.661


  14 in total

1.  Incidence of rhesus immunisation after genetic amniocentesis.

Authors:  A Tabor; D Jerne; J E Bock
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-30

Review 2.  The role of antenatal immunoprophylaxis in the prevention of maternal-foetal anti-Rh(D) alloimmunisation.

Authors:  Giancarlo Maria Liumbruno; Angelo D'Alessandro; Federica Rea; Vanessa Piccinini; Liviana Catalano; Gabriele Calizzani; Simonetta Pupella; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2010-01       Impact factor: 3.443

3.  Antenatal assessment of the fetus.

Authors:  L M Hanson
Journal:  Can Fam Physician       Date:  1986-10       Impact factor: 3.275

4.  Prevention of Rh(D) alloimmunization: a cost-benefit analysis.

Authors:  T F Baskett; M L Parsons
Journal:  CMAJ       Date:  1990-02-15       Impact factor: 8.262

5.  Screening in pregnancy.

Authors:  A Biringer
Journal:  Can Fam Physician       Date:  1988-09       Impact factor: 3.275

6.  Recommendations for the prevention and treatment of haemolytic disease of the foetus and newborn.

Authors:  Francesco Bennardello; Serelina Coluzzi; Giuseppe Curciarello; Tullia Todros; Stefania Villa
Journal:  Blood Transfus       Date:  2015-01       Impact factor: 3.443

7.  Efficacy and long term effects of antenatal prophylaxis with anti-D immunoglobulin.

Authors:  J G Thornton; C Page; G Foote; G R Arthur; L A Tovey; J S Scott
Journal:  BMJ       Date:  1989-06-24

Review 8.  Noninvasive Fetal RhD Blood Group Genotyping: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2020-11-02

9.  Antigen modulation as a potential mechanism of anti-KEL immunoprophylaxis in mice.

Authors:  Jingchun Liu; Manjula Santhanakrishnan; Prabitha Natarajan; David R Gibb; Stephanie C Eisenbarth; Christopher A Tormey; Alexa J Siddon; Sean R Stowell; Donald R Branch; Jeanne E Hendrickson
Journal:  Blood       Date:  2016-09-29       Impact factor: 22.113

10.  Poly(I:C) causes failure of immunoprophylaxis to red blood cells expressing the KEL glycoprotein in mice.

Authors:  Vicente Escamilla-Rivera; Jingchun Liu; David R Gibb; Manjula Santhanakrishnan; Dong Liu; James E Forsmo; Stephanie C Eisenbarth; Ellen F Foxman; Sean R Stowell; Chance John Luckey; James C Zimring; Krystalyn E Hudson; Jeanne E Hendrickson
Journal:  Blood       Date:  2020-05-28       Impact factor: 25.476
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.